An observational study in Thyroid, sponsored by Mayo Clinic. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.
Sponsored by Mayo Clinic · Observational
The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.
365 studies on the registry are indexed under Thyroid Diseases; 80 are open to participants now.
This study's planned enrollment of 300 is above the median of 198 across 158 observational studies indexed under Thyroid Diseases.
Browse Thyroid Diseases studies →Mayo Clinic is the lead sponsor of 3,269 studies on the registry; 672 are open to participants now.
Of its 452 completed or terminated interventional studies of FDA-regulated products, 321 (71%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult patients undergoing ablation for symptomatic thyroid nodule(s)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Undergoing Radiofrequency Ablation (RFA) for symptomatic thyroid nodule(s).
Exclusion Criteria:
- Decline to participate in research.
Change in symptoms before and after ablation
Measured using a modified 6-item SYS questionnaire that objectively measures patient symptoms on a scale of 0=none, 1=moderate, 2=severe
Time frame: Baseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment
Plan to share: No
Started Aug 2022 (actual). Primary completion is estimated for Aug 2028, 72 months after the start.
Of 69 non-industry observational studies under Thyroid Diseases, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 203. This study's planned 72 months is above that.
Counting every sponsor, half of 74 studies reached it within 30 months; a quarter within 12 and three quarters within 203.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.